Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma
Melanoma
Squamous Cell Carcinoma of Head and Neck
Breast Neoplasms
Uterine Cervical Neoplasms
Vulvar Neoplasms
Penile Neoplasms
Anus Neoplasms

Interventions

BIOLOGICAL: Stimotimagene copolymerplasmid
DRUG: Ganciclovir

Sponsor

Gene Surgery LLC